 | Current Price Targets For Celyad SA (CYAD) - NewsDen (NASDAQ:CYAD)
newsden.net - September 28 at 9:25 AM |
 | Biggest Movers in Manufacturing Stocks Now - IPCI ARDM GLMD PTI - Investorplace.com (NASDAQ:CYAD)
investorplace.com - September 24 at 4:21 PM |
| Celyad SA (CYAD) Sets New 12-Month Low at $20.90 - NewsDen (NASDAQ:CYAD)
newsden.net - September 20 at 8:11 AM |
 | CELYAD S.A.: Celyad CEO to present at the 2016 Cell & Gene Meeting on the Mesa - GlobeNewswire (press release) (NASDAQ:CYAD)
globenewswire.com - September 15 at 8:40 AM |
| Analysts Place Celyad SA (ADR) (NASDAQ:CYAD) Under the Lens of the Microscope - Post News (NASDAQ:CYAD)
www.kentuckypostnews.com - September 15 at 8:40 AM |
 | Celyad CEO to present at the 2016 Cell & Gene Meeting on the Mesa (NASDAQ:CYAD)
www.publicnow.com - September 15 at 8:40 AM |
| Analysts Take: Celyad SA (ADR) (NASDAQ:CYAD) Projected Earnings & Price Targets - Frisco Fastball (NASDAQ:CYAD)
friscofastball.com - September 14 at 9:46 PM |
 | Celyad SA (CYAD) Announces Completion of NKR-2 Phase I in AML - StreetInsider.com (NASDAQ:CYAD)
www.streetinsider.com - September 10 at 9:09 AM |
| Celyad SA (CYAD) Announces Completion of NKR-2 Phase I in AML (NASDAQ:CYAD)
www.streetinsider.com - September 9 at 9:23 AM |
 | CELYAD S.A.: Celyad completes the NKR-2 Phase I trial with successful safety follow-up of the fourth dose level (NASDAQ:CYAD)
finance.yahoo.com - September 9 at 9:23 AM |
| Celyad completes the NKR-2 Phase I trial with successful safety follow-up of the fourth dose level (NASDAQ:CYAD)
www.publicnow.com - September 9 at 9:23 AM |
| Placing Celyad SA (ADR) (NASDAQ:CYAD) Shares Under the Microscope - Post News (NASDAQ:CYAD)
www.kentuckypostnews.com - September 8 at 8:20 AM |
| Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1): Clinical Trial Primary Outcomes (NASDAQ:CYAD)
www.publicnow.com - September 1 at 4:28 PM |
| Stock in Review: Taking a Closer Look at Celyad SA (ADR) (NASDAQ:CYAD) Shares - Post News (NASDAQ:CYAD)
www.kentuckypostnews.com - September 1 at 9:34 AM |
| Celyad appoints Philippe Dechamps as General Counsel and Company Secretary (NASDAQ:CYAD)
www.publicnow.com - September 1 at 9:34 AM |
| Prof. Jozef Bartunek presented CHART-1 Phase III Results Outline at ESC 2016 (NASDAQ:CYAD)
www.publicnow.com - August 31 at 9:23 AM |
| Celyad Reports First Half 2016 Financial Results and Operational Progress (NASDAQ:CYAD)
finance.yahoo.com - August 25 at 9:28 AM |
| Sell-side & Crowd View on Celyad SA (ADR) (NASDAQ:CYAD) - Post News (NASDAQ:CYAD)
www.kentuckypostnews.com - August 20 at 5:34 AM |
| What is the Street Saying About Celyad SA (ADR) (NASDAQ:CYAD)? - Post News (NASDAQ:CYAD)
www.kentuckypostnews.com - August 19 at 9:26 AM |
| Crowd & Street Analysis on Celyad SA (ADR) (NASDAQ:CYAD) - Post News (NASDAQ:CYAD)
www.kentuckypostnews.com - August 18 at 4:35 PM |
| Celyad Letter for Shareholders (NASDAQ:CYAD)
www.publicnow.com - August 8 at 9:22 AM |
| Transparency notification of Medisun International Limited and National Investment Fund Ltd (NASDAQ:CYAD)
www.publicnow.com - August 5 at 4:33 PM |
 | Celyad SA :CYAD-US: Earnings Analysis: For the six months ended December 31, 2015 : July 27, 2016 (NASDAQ:CYAD)
www.capitalcube.com - July 27 at 10:52 AM |
| Celyad SA :CYAD-BE: Earnings Analysis: For the six months ended December 31, 2015 : July 22, 2016 (NASDAQ:CYAD)
www.capitalcube.com - July 22 at 3:34 AM |
| Celyad SA :CYAD-BE: Earnings Analysis: 2015 By the Numbers : July 22, 2016 (NASDAQ:CYAD)
www.capitalcube.com - July 22 at 2:11 AM |
| Celyad SA (ADR) (NASDAQ:CYAD): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:CYAD)
www.engelwooddaily.com - July 20 at 9:51 AM |
| Celyad SA Ads (NASDAQ:CYAD) Sellers Increased By 13.81% Their Shorts - Consumer Eagle (NASDAQ:CYAD)
www.consumereagle.com - July 20 at 9:51 AM |
| Trading Performance and Target Watch for Celyad SA (ADR) (NASDAQ:CYAD) - Press Telegraph (NASDAQ:CYAD)
presstelegraph.com - July 18 at 9:35 AM |
 | Celyad SA (CYAD) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:CYAD)
www.fiscalstandard.com - July 17 at 4:18 PM |
 | Celyad : successfully completes safety follow-up of the first patient at the fourth dose level in the NKR-2 Phase I trial (NASDAQ:CYAD)
www.4-traders.com - July 14 at 10:01 PM |
 | CELYAD S.A.: Celyad successfully completes safety follow-up of the first patient at the fourth dose level in the NKR-2 Phase I trial (NASDAQ:CYAD)
www.msn.com - July 14 at 10:01 PM |
| Celyad SA Ads (NASDAQ:CYAD) Short Interest Increased By 8.67% - Consumer Eagle (NASDAQ:CYAD)
www.consumereagle.com - July 14 at 7:16 AM |
| Celyad successfully completes safety follow-up of the first patient at the fourth dose level in the NKR-2 Phase I trial (NASDAQ:CYAD)
www.publicnow.com - July 14 at 1:48 AM |
| Celyad SA (ADR) (NASDAQ:CYAD) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:CYAD)
www.engelwooddaily.com - July 12 at 4:41 PM |
| CELYAD S.A.: Celyad enters into license agreement with ONO PHARMACEUTICAL CO., LTD. to develop allogeneic NKR-2 T-cell immunotherapy (NASDAQ:CYAD)
www.msn.com - July 11 at 4:32 PM |
| Celyad SA (CYAD) Enters Licensing Agreement with ONO Pharma for NKR-2 T-cell Immunotherapy (NASDAQ:CYAD)
www.streetinsider.com - July 11 at 4:32 PM |
| Celyad SA (CYAD) Enters Licensing Agreement with ONO Pharma for NKR-2 T-cell Immunotherapy - StreetInsider.com (NASDAQ:CYAD)
www.streetinsider.com - July 11 at 9:20 AM |
 | Weekly Biotech Report Covering Gilead Sciences, Inc. (GILD) and Celyad SA (ADR) (CYAD) - Insider Monkey (blog) (NASDAQ:CYAD)
www.insidermonkey.com - July 8 at 10:02 AM |
| Weekly Biotech Report Covering Gilead Sciences, Inc. (GILD) and Celyad SA (ADR) (CYAD) (NASDAQ:CYAD)
feedproxy.google.com - July 7 at 2:52 PM |
| Celyad SA (CYAD) Current Analyst Ratings - Fiscal Standard (NASDAQ:CYAD)
www.fiscalstandard.com - July 7 at 9:47 AM |
 | ANTH Dims On BRIGHT-SC Data, CYAD Fails To Chart, LLY Gets FDA Panel Nod - Nasdaq (NASDAQ:CYAD)
www.nasdaq.com - July 1 at 9:39 PM |
| Celyad SA Ads (NASDAQ:CYAD) Shorted Shares Increased 8.67% After Market Selling - Engelwood Daily (NASDAQ:CYAD)
www.engelwooddaily.com - June 30 at 10:31 AM |
| Brokers Issue Average Price Target Of 87.00 On Celyad SA (CYAD) - Fiscal Standard (NASDAQ:CYAD)
www.fiscalstandard.com - June 30 at 10:31 AM |
 | New Broker Ratings For Celyad SA (CYAD) - FTSE News (NASDAQ:CYAD)
www.ftsenews.co.uk - June 29 at 9:32 PM |
| Celyad SA (CYAD) Says CHART-1 Trial Results Not Statistically Significant (NASDAQ:CYAD)
www.streetinsider.com - June 29 at 4:28 PM |
 | 7 Biggest Mid-Day Losers For Tuesday - Benzinga (NASDAQ:CYAD)
www.benzinga.com - June 28 at 9:39 PM |
| Next Weeks Broker Price Targets For Celyad SA (CYAD) - Fiscal Standard (NASDAQ:CYAD)
www.fiscalstandard.com - June 28 at 9:39 PM |
| Celyad SA (EBR:CYAD)'s Company Shares Decreased 16.62% After Low Volatility - Press Telegraph (NASDAQ:CYAD)
presstelegraph.com - June 28 at 9:39 PM |
| Celyad SA (CYAD) Says CHART-1 Trial Results Not Statistically Significant - StreetInsider.com (NASDAQ:CYAD)
www.streetinsider.com - June 28 at 9:39 PM |
| CELYAD S.A.: Celyad Announces Results for the CHART-1 Phase III Clinical Trial Evaluating C-Cure(R) Cell Therapy (NASDAQ:CYAD)
www.msn.com - June 28 at 4:30 PM |
